Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Iroxanadine

🥰Excellent
Catalog No. T27627Cas No. 203805-20-3
Alias BRX-235, BRX235, BRX-005, BRX005, BRX 235, BRX 005

Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.13480-84-5

Iroxanadine

Iroxanadine

🥰Excellent
Purity: 100%
Catalog No. T27627Alias BRX-235, BRX235, BRX-005, BRX005, BRX 235, BRX 005Cas No. 203805-20-3
Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.13480-84-5
Pack SizePriceAvailabilityQuantity
1 mg$146In Stock
5 mg$350In Stock
10 mg$530In Stock
25 mg$859In Stock
50 mg$1,180In Stock
100 mg$1,590In Stock
500 mg$3,190In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Iroxanadine"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.13480-84-5
In vivo
Iroxanadine improves the survival of vascular endothelial cells (ECs) following ischemia/reperfusion stress. ECs cultured from human umbilical veins were exposed to hypoxia/reoxygenation to mimic ischemia/reperfusion. Caspase activation and apoptosis were monitored in the reoxygenated cells. The addition of Iroxanadine (0.1-1 μM) to the culture medium prior to hypoxia or at the start of reoxygenation significantly reduced the caspase-dependent apoptosis.[1]
AliasBRX-235, BRX235, BRX-005, BRX005, BRX 235, BRX 005
Chemical Properties
Molecular Weight260.33
FormulaC14H20N4O
Cas No.203805-20-3
SmilesC(C1NC(=NOC1)C=2C=CC=NC2)N3CCCCC3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (172.86 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.8413 mL19.2064 mL38.4128 mL192.0639 mL
5 mM0.7683 mL3.8413 mL7.6826 mL38.4128 mL
10 mM0.3841 mL1.9206 mL3.8413 mL19.2064 mL
20 mM0.1921 mL0.9603 mL1.9206 mL9.6032 mL
50 mM0.0768 mL0.3841 mL0.7683 mL3.8413 mL
100 mM0.0384 mL0.1921 mL0.3841 mL1.9206 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Iroxanadine | purchase Iroxanadine | Iroxanadine cost | order Iroxanadine | Iroxanadine chemical structure | Iroxanadine in vivo | Iroxanadine formula | Iroxanadine molecular weight